Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1992 Jul;23(1):30-41.
doi: 10.2165/00003088-199223010-00003.

Intranasal insulin. Clinical pharmacokinetics

L Illum  1 , S S Davis
Affiliations
Review

Intranasal insulin. Clinical pharmacokinetics

L Illum et al. Clin Pharmacokinet. 1992 Jul.

Abstract

Insulin administered nasally has considerable potential for the treatment of both insulin-dependent (IDDM) and non-insulin-dependent (NIDDM) diabetes. For patients with NIDDM it is possible to prevent preprandial hyperglycaemia and postprandial hypoglycaemia by employing a suitable and properly timed intranasal insulin dose. The low bioavailability of simple formulations of insulin can be greatly improved by using absorption enhancers or novel delivery systems such as bioadhesive microspheres. The need for nontoxic and nonirritant systems is stressed.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Trends Pharmacol Sci. 1990 Sep;11(9):353-5 - PubMed
    1. Diabetes Care. 1984 Mar-Apr;7(2):188-99 - PubMed
    1. Diabetes Care. 1980 Mar-Apr;3(2):270-3 - PubMed
    1. Diabetes. 1988 Feb;37(2):246-51 - PubMed
    1. Endocrinology. 1972 Mar;90(3):624-31 - PubMed

LinkOut - more resources